Skip to content

Clinical trials

Phase 2 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2 Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20047
20054
200613
200715
200812
20097
20108
20117
20128
20133
20146
201516
20163
20175
20186
20198
20205
20212
20227
20234
20242
20254
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Terminated33
Unknown status11
Recruiting8
Withdrawn7
Not yet recruiting5
Active, not recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan10
Alcon Research6
National Eye Institute (NEI)6
Novartis Pharmaceuticals6
GlaxoSmithKline5
Snyder, Robert W., M.D., Ph.D., P.C.4
Genaera Corporation3
Genentech, Inc.3
Manhattan Eye, Ear & Throat Hospital3
Ophthotech Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration168
Geographic Atrophy29
Choroidal Neovascularization27
Retinal Diseases10
Wet Macular Degeneration10
Eye Diseases9
Retinal Degeneration8
Diabetic Retinopathy6
Macular Edema6
Vision Disorders5

Trials

Showing 76 to 100 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.